Bradley J. Martin, Ph.D.

Biographical Sketch

Dr. Martin brings over 15 years of experience in the field of cardiovascular physiology and regenerative medicine. Much of his career has focused on the development of stem cell therapies for the treatment of myocardial infarction and heart failure. He has considerable experience in the development of preclinical models of disease and the generation of non-clinical safety and efficacy packages in support of successful IND submissions. He is a recognized leader in the field of translational research, and currently serves on the editorial board of the Journal of Cardiovascular Translational Research. He has a strong track record of leading projects and cross functional project teams in the completion of milestone driven goals. Prior to joining IDSC, Dr. Martin was the Director of Product Development at Aastrom Biosciences, and the Director of Cardiac Research at Osiris Therapeutics Inc. He also spent 3 years as a Principal Scientist with Pfizer's Esperion Division studying the anti-atherosclerotic properties of ApoA-I Milano, and other novel peptides. He received in Ph.D. in Physiology in 1993 from the University of Michigan, and completed post-doctoral fellowships in the Depts. of Cardiothoracic Surgery and Physiology at the University of Wisconsin.